New injection could spare cancer patients from frequent fluid drains
NCT ID NCT06432296
First seen May 12, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study tests a drug called M701 for people with advanced cancer that causes fluid buildup in the belly (malignant ascites). The drug is injected into the belly to see if it can delay the need for draining the fluid. About 312 adults with stomach, colorectal, or ovarian cancer will take part. The goal is to improve comfort and reduce the number of drainage procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT ASCITES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
The First Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, 100141, China
Conditions
Explore the condition pages connected to this study.